Guizhou Bailing Group Pharmaceutical Co Ltd (002424) — Cash Flow-to-Debt Ratio
Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has a Cash Flow-to-Debt Ratio of 0.10x as of September 2025, meaning its operating cash flow of CN¥294.76 Million could theoretically repay 0% of its total liabilities (CN¥3.00 Billion) in one year. Explore how much of Guizhou Bailing Group Pharmaceutical Co 's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Guizhou Bailing Group Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Guizhou Bailing Group Pharmaceutical Co Ltd across 19 annual periods. Also explore Guizhou Bailing Group Pharmaceutical Co assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Guizhou Bailing Group Pharmaceutical Co Ltd (2007–2025)
Year-by-year debt coverage analysis for Guizhou Bailing Group Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see how much is Guizhou Bailing Group Pharmaceutical Co worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | CN¥748.72 Million | CN¥3.02 Billion | ▲ +10707.0% |
| 2024 | 0.00x | CN¥9.02 Million | CN¥3.94 Billion | ▼ -93.0% |
| 2023 | 0.03x | CN¥125.77 Million | CN¥3.82 Billion | ▼ -81.0% |
| 2022 | 0.17x | CN¥502.15 Million | CN¥2.90 Billion | ▲ +34.9% |
| 2021 | 0.13x | CN¥324.92 Million | CN¥2.53 Billion | ▲ +72.5% |
| 2020 | 0.07x | CN¥231.78 Million | CN¥3.11 Billion | ▼ -53.6% |
| 2019 | 0.16x | CN¥467.41 Million | CN¥2.91 Billion | ▲ +309.1% |
| 2018 | -0.08x | CN¥-157.45 Million | CN¥2.05 Billion | ▼ -230.2% |
| 2017 | 0.06x | CN¥79.88 Million | CN¥1.36 Billion | ▼ -85.2% |
| 2016 | 0.40x | CN¥466.62 Million | CN¥1.17 Billion | ▲ +11.9% |
| 2015 | 0.36x | CN¥413.23 Million | CN¥1.16 Billion | ▲ +9.5% |
| 2014 | 0.33x | CN¥395.83 Million | CN¥1.22 Billion | ▲ +210.1% |
| 2013 | 0.10x | CN¥141.76 Million | CN¥1.35 Billion | ▲ +543.4% |
| 2012 | 0.02x | CN¥19.52 Million | CN¥1.20 Billion | ▼ -91.3% |
| 2011 | 0.19x | CN¥201.90 Million | CN¥1.08 Billion | ▲ +139.8% |
| 2010 | -0.47x | CN¥-447.68 Million | CN¥952.49 Million | ▼ -267.1% |
| 2009 | 0.28x | CN¥125.31 Million | CN¥445.48 Million | ▲ +323.2% |
| 2008 | -0.13x | CN¥-40.42 Million | CN¥320.72 Million | ▲ +49.8% |
| 2007 | -0.25x | CN¥-79.37 Million | CN¥315.87 Million | — |